Depression is relatively common among men with prostate cancer. Indeed, it may be a lot more common than we can currently document. … READ MORE …
Filed under: Uncategorized | Tagged: ADT, androgen, cancer, depression, deprivation, prostae, risk | 3 Comments »
According to a recently reported study in the journal European Urology, men who received first-line surgery or radiation therapy for non-metastatic prostate cancer were significantly more likely to have taken an antidepressant 5 years later than comparable men who didn’t get such treatment. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: antidepressant, depression, monitoring, radiartion, surgery, surveillance, therapy | 7 Comments »
A new report in the journal JAMA Oncology is said to have detailed “the psychological damage” that a cancer diagnosis “often leaves in its wake for patients.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: depression, Diagnosis, disorder, mental, risk, stress, time | 5 Comments »
It will come as no great surprise to most readers of this blog that androgen deprivation therapy (ADT) used in the treatment of men with progressive forms of prostate cancer comes with a significant risk for depression (as well as other effects on cognitive function). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, depression, deprivation, hormone, Management | 1 Comment »
In a rather less that surprising finding, a new paper in the Journal of Clinical Oncology reports that men with existing depressive disorders at the time of diagnosis with prostate cancer “are less likely to undergo definitive treatment and experience worse overall survival.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: depression, Diagnosis, outcome, response, Treatment | 1 Comment »
The association of depression with a diagnosis of and subsequent treatment for prostate cancer is well appreciated, but the prevalence of that depression and the burden it places on men with prostate cancer over time has been less well documented. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: depression, mortality, outcome, risk | 5 Comments »
A new paper in the European Journal of Cancer suggests that men with prostate cancer are at increased risk for depression, for post-traumatic stress disorder, and for use of antidepressant drugs compared to age-matched controls. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anxiety, depression, post-traumatic stress disorder, risk, Sweden, Treatment | 3 Comments »
It is unlikely to come as any big surprise to the average prostate cancer patient who was potent before first-line therapy but has erectile dysfunction (ED) afterward that there might be an association between ED and depression after initial treatment for localized prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: depression, ED, erectile dysfunction | 6 Comments »
There has been good evidence that older cancer patients report less “distress” than younger cancer patients. However, there has been very little research to date into the distinctions among general distress, anxiety, and depression in aging prostate cancer patients. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: age, anxiety, depression, distress | Leave a comment »
One of the issues that worries people about active surveillance and other forms of “non-interventional” management for prostate cancer is whether patients will suffer unduly from anxiety and distress while living with “untreated” cancer. We know that there are patients who have been on such protocols long-term who do not; we also know that there are some patients who find the idea of living with “untreated” prostate cancer too difficult to deal with. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, anxiety, depression, distress | 6 Comments »
Looking through my assorted notes from the meeting this morning after getting home late last night, there are four other poster presentations that are worth commenting on very specifically, and then a general comment that I would add. … READ MORE …
Filed under: Management, Treatment | Tagged: abiraterone, active surveillance, anxiety, cost, depression, MDV3100, radical prostatectomy | Leave a comment »
We have separately commented on a Swedish pilot study showing that men treated with captopril following radical prostatectomy had a significant reduction in risk of biochemical recurrence. Other reports today deal with:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", contrast-enhanced eMRI, depression, hot flashes, mortality, surgery | Leave a comment »
The important news today appears to be clear confirmation that a high- (or low-) fiber diet won’t affect your risk for prostate cancer (at least, not over an 8-year timeframe). In other news today:
Filed under: Living with Prostate Cancer, Management, Prevention, Tips, Treatment | Tagged: androgen, depression, deprivation, diet, fiber, positive surgical margin, risk | Leave a comment »
Newly published studies today include data on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: androgen deprivation, antiandrogen, atypia, bicalutamide, brachytherapy, cancer, depression, fatigue, flutamide, irritability, mood, prostate, quality of life, radiotherapy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 